Damages caused by KORUS FTA in drug industry addressed to political circles.

Published: 2007-04-24 06:57:00

Updated: 2007-04-24 06:57:00

The drug industry strongly claimed that the implementation of government's positive list system and cGMP should be postponed and the industry needed the government's tax privileges to cope with industrial damages possibly stemming from the KORUS FTA, the amount of which showed far worse than the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK